This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Massachusetts Eye and Ear Infirmary. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Emily Brown - Innovator in Gene Therapy
Introduction
Emily Brown is a prominent inventor based in Boston, MA, specializing in gene therapy. She has made significant contributions to the field, particularly in addressing retinal degeneration associated with specific genetic mutations. Her work is vital for advancing treatment options for patients suffering from these conditions.
Latest Patents
Emily holds a patent for her innovative work titled "Gene therapy for NMNAT1-associated retinal degeneration - Methods and compositions for gene therapy of retinal degeneration related to mutations in nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1)." This patent represents a crucial step forward in the development of therapeutic strategies for retinal diseases.
Career Highlights
Emily is affiliated with the Massachusetts Eye and Ear Infirmary, where she conducts her research and development efforts. Her role at this esteemed institution allows her to collaborate with leading experts in the field and contribute to groundbreaking advancements in ophthalmology.
Collaborations
Emily has worked alongside notable colleagues, including Eric A. Pierce and Luk H. Vandenberghe. Their combined expertise enhances the research environment and fosters innovative solutions to complex medical challenges.
Conclusion
Emily Brown's contributions to gene therapy exemplify the impact of innovative research on improving patient outcomes. Her dedication to advancing medical science continues to inspire future generations of inventors and researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile